Skip to main content
← Employer Benefits IQ

Definitive Guide

High-cost care & clinical strategy

Employer High-Cost Care Strategy: A Definitive Guide

A definitive guide to care pathways, complex-case support and accountable clinical strategy for employers.

By Corry Hull, REBC®, CSFS® — Vice President of Employee Benefits at BHC Insurance

High-cost claims are financial signals, but the events behind them are care-pathway decisions. A high-performance employer does not wait for a complex episode to appear on a large-claim report. It builds a strategy that helps members find clinically appropriate support, providers and information before consequential choices become fixed.

Identify the episodes that deserve attention. Review recurring high-cost categories, oncology, musculoskeletal care, maternity, cardiovascular conditions, specialty medication and site-of-care patterns with appropriate clinical context. The objective is to find where earlier guidance or a better pathway could improve care—not to target individuals based on cost alone.

Define the support model. Navigation, second opinions, centers of excellence, case management and condition-specific programs should work as a coordinated experience. For every pathway, clarify who engages the member, when the offer is made, what decision it helps with and how the member moves between services.

Second opinions can be valuable when they are timely, clinically credible and connected to the next step. They should reduce uncertainty around diagnosis, treatment options or site of care rather than creating another disconnected requirement for someone already facing a serious condition.

Centers of excellence require a usable referral process. Price and quality evidence matter, but so do travel support, caregiver needs, local follow-up and the employee’s informed choice. A preferred center that is impossible to reach will not create the intended clinical or financial value.

Integrate pharmacy and specialty care decisions. Many high-cost episodes include complex drug therapies whose authorization, sourcing and adherence support affect both the clinical plan and the economic result. Separate vendor programs should share appropriate information and avoid asking the member to coordinate the system alone.

Use claims reporting responsibly. Aggregate patterns can identify opportunities; individual case information should be managed only by qualified parties with proper privacy safeguards. Employer leaders need decision-ready oversight, not clinical details they are not positioned to receive or use.

Measure more than savings. Review engagement at the right time, pathway completion, care-setting changes, member experience, quality indicators when available and the integrity of vendor reporting. A narrow savings claim may miss disruption, delayed care or a failure to support the member’s actual decision.

A strong first step is to choose one high-consequence pathway, document the current member journey and establish an accountable cross-vendor review. That makes complex care an intentional strategy rather than a post-claim response.